These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 170076)

  • 1. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental neuropathy due to acrilamide. Histological and ultrastructural studies (author's transl)].
    Simonati A; Terzian H; Rizzuto N
    Riv Patol Nerv Ment; 1978 Sep; 98(4):213-27. PubMed ID: 217078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and morphological findings in acrylamide toxicity.
    Le Quesne PM
    Neurotoxicology; 1985; 6(4):17-24. PubMed ID: 4088539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure.
    Spencer PS; Schaumburg HH
    Can J Neurol Sci; 1974 May; 1(2):143-50. PubMed ID: 4373158
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication.
    Schaumburg HH; Wiśniewski HM; Spencer PS
    J Neuropathol Exp Neurol; 1974 Apr; 33(2):260-84. PubMed ID: 4362700
    [No Abstract]   [Full Text] [Related]  

  • 8. "Giant axonal neuropathy" caused by industrial chemicals: neurofilamentous axonal masses in man.
    Davenport JG; Farrell DF; Sumi M
    Neurology; 1976 Oct; 26(10):919-23. PubMed ID: 183168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmyelinated nerve fibres in feline acrylamide neuropathy.
    Post EJ
    Acta Neuropathol; 1978 Apr; 42(1):19-24. PubMed ID: 207070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occupational toxic neuropathies: morphology in peripheral nerve biopsies].
    Scelsi R; Candura SM
    G Ital Med Lav Ergon; 2012; 34(4):410-9. PubMed ID: 23477107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide monomer and peripheral neuropathy in chemical workers.
    Bachmann M; Myers JE; Bezuidenhout BN
    Am J Ind Med; 1992; 21(2):217-22. PubMed ID: 1311148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow recovery of central axons in acrylamide neuropathy.
    Kaji R; Liu Y; Duckett S; Sumner AJ
    Muscle Nerve; 1989 Oct; 12(10):816-26. PubMed ID: 2558312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrylamide and polyacrylamide: a review of production, use, environmental fate and neurotoxicity.
    Smith EA; Oehme FW
    Rev Environ Health; 1991; 9(4):215-28. PubMed ID: 1668792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration.
    Gold BG; Griffin JW; Price DL
    J Neurosci; 1985 Jul; 5(7):1755-68. PubMed ID: 2410575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function.
    Ko MH; Chen WP; Lin-Shiau SY; Hsieh ST
    Exp Neurol; 1999 Jul; 158(1):37-46. PubMed ID: 10448416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):771-5. PubMed ID: 171344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and morphologic characterization of acrylamide peripheral neuropathy.
    Lehning EJ; Persaud A; Dyer KR; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):211-21. PubMed ID: 9707497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrylamide poisoning.
    Kesson CM; Baird AW; Lawson DH
    Postgrad Med J; 1977 Jan; 53(615):16-7. PubMed ID: 195278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrylamide neuropathy: selective vulnerability of sensory fibers.
    Sumner AJ; Asbury AK
    Trans Am Neurol Assoc; 1974; 99():79-83. PubMed ID: 4377051
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropathology of skin denervation in acrylamide-induced neuropathy.
    Ko MH; Chen WP; Hsieh ST
    Neurobiol Dis; 2002 Oct; 11(1):155-65. PubMed ID: 12460555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.